封面
市場調查報告書
商品編碼
1547504

全球乾眼症治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Dry Eye Disease Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

全球乾眼症治療市場需求預計將從2023年的59.9億美元達到2032年近89.4億美元的市場規模,2024-2032年研究期間複合年成長率為4.55%。

乾眼症是一個術語,定義感染者眼睛表面缺乏潤滑或水分。這是一種常見的疾病,幾乎可以影響任何人。乾眼症的症狀很多,包括疼痛和灼熱感、眼睛發紅、眼睛疲勞、眼睛發癢、畏光、眼睛酸痛、流淚等。 、吸煙、LASIK 眼科手術、荷爾蒙替代療法等。

市場動態

過度使用智慧型手機和電腦、人口老化(極易患有乾眼症)以及其他風險因素正在主導乾眼症治療市場。根據《2019 年世界人口展望》估計,全球約 9% 的人口年齡在 65 歲以上,到 2050 年,這一比例預計將佔全球人口的近 17%。患有糖尿病、甲狀腺疾病、紅斑性狼瘡、硬皮症、乾燥症、類風濕性關節炎等疾病的人罹患乾眼症的風險很高。這些疾病盛行率的擴大往往會導致乾眼症發生率的上升。意識水平的提高、診斷率的提高、更好的治療選擇的可用性是促進市場成長的其他因素。然而,患者自我藥療的盛行以及對乾眼症的認知較低可能會成為市場的限制。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球乾眼症治療市場的各個細分市場進行了包容性評估。乾眼症治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

乾眼症治療市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 人工淚液
  • 抗發炎(環孢素、皮質類固醇、其他)
  • 淚點塞
  • 秘密煽動者
  • 其他

按疾病分類

  • 蒸發性乾眼症
  • 水樣乾眼症

按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲乾眼症治療市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。乾眼症治療市場的主要參與者包括諾華公司、艾爾建、Bausch Health Companies Inc.、參天製藥有限公司、OASIS Medical。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:乾眼症治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按疾病分類的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球乾眼症治療市場分析:依產品分類

  • 概述(按產品)
  • 按產品分類的歷史和預測資料分析
  • 人工淚液
  • 抗發炎(環孢素、皮質類固醇、其他)
  • 淚點塞
  • 秘密煽動者
  • 其他

第 6 章:全球乾眼症治療市場分析:依疾病分類

  • 按疾病分類概述
  • 按疾病分類的歷史和預測資料分析
  • 蒸發性乾眼症
  • 水樣乾眼症

第 7 章:全球乾眼症治療市場分析:按分銷管道

  • 配銷通路概述
  • 按配銷通路進行歷史和預測資料分析
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 8 章:全球乾眼症治療市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章:乾眼症治療公司的競爭格局

  • 乾眼症治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Allergan
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bausch Health Companies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Santen Pharmaceutical Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • OASIS Medical
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資訊和最新發展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR11215140

The global demand for Dry Eye Disease Treatment Market is presumed to reach the market size of nearly USD 8.94 Billion by 2032 from USD 5.99 Billion in 2023 with a CAGR of 4.55% under the study period 2024-2032.

Dry eye disease is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a usually occurring disease that can affect almost anyone. Numerous dry eye symptoms include aching and burning sensations, red eyes, tired eyes, itchy eyes, photophobia, sore eyes, watery eyes, etc. Factors causing dry eye syndrome include excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

MARKET DYNAMICS

Excessive use of smartphones & computers, expanding aging population, which is highly prone to the syndrome, and other risk factors are steering the dry eye disease treatment market. As per World Population Prospects 2019 estimates, around 9% of the global population is over 65 years of age, and by 2050 this is expected to account for nearly 17% of the worldwide population. Individuals with diseases such as diabetes, thyroid disorders, lupus, scleroderma, Sjogren's syndrome, rheumatoid arthritis are at high risk of causing dry eye disease. Expanding prevalence of these diseases will tend to cause a rise in the incidence of dry eye disease. Increasing awareness levels, rising diagnostic rates, availability of better treatment options are other factors augmenting the market's growth. However, the prevalence of self-medication by patients and low awareness about dry eye disease are likely to act as market restraints.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Dry Eye Disease Treatment. The growth and trends of Dry Eye Disease Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Dry Eye Disease Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Artificial Tears
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others)
  • Punctal Plugs
  • Secretagogue
  • Others

By Disease

  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dry Eye Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dry Eye Disease Treatment market include Novartis AG, Allergan, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., OASIS Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DRY EYE DISEASE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Artificial Tears Historic and Forecast Sales By Regions
  • 5.4. Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Historic and Forecast Sales By Regions
  • 5.5. Punctal Plugs Historic and Forecast Sales By Regions
  • 5.6. Secretagogue Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY DISEASE

  • 6.1. Overview By Disease
  • 6.2. Historical and Forecast Data Analysis By Disease
  • 6.3. Evaporative Dry Eye Syndrome Historic and Forecast Sales By Regions
  • 6.4. Aqueous Dry Eye Syndrome Historic and Forecast Sales By Regions

7. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRY EYE DISEASE TREATMENT COMPANIES

  • 9.1. Dry Eye Disease Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF DRY EYE DISEASE TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Novartis AG
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Allergan
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bausch Health Companies Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Santen Pharmaceutical Co. Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. OASIS Medical
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Artificial Tears Market Sales By Geography (USD MN)
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Market Sales By Geography (USD MN)
  • Punctal Plugs Market Sales By Geography (USD MN)
  • Secretagogue Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Disease (USD MN)
  • Evaporative Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Aqueous Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Dry Eye Disease Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dry Eye Disease Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Dry Eye Disease Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Artificial Tears Market Sales By Geography (USD MN)
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Market Sales By Geography (USD MN)
  • Punctal Plugs Market Sales By Geography (USD MN)
  • Secretagogue Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease (USD MN)
  • Evaporative Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Aqueous Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.